Covidien Invests $18 Million To Establish Hillsborough County, Florida, Medical Device Facility
Area Development Online News Desk (11/22/2013)
Covidien, a global provider of healthcare products, will invest $18 million to establish a medical device manufacturing facility in Hillsborough County, Florida. Covidien is leasing temporary space in Sabal Park, with plans to occupy a 62,200 square foot facility in Riverview by mid-2014. The project is expected to create up to 165 new jobs.
“We are pleased to locate a medical devices manufacturing facility in Hillsborough County,” said Phil Devlin, Vice President and General Manager, Covidien. “We specifically selected Hillsborough County for several reasons, including its talented workforce and the Tampa Bay region’s business climate, economy and quality of life. Our new facility will not only provide jobs for the local community, it will support Florida’s growing life science industry as well.”
Gov. Rick Scott said, “Covidien’s decision to expand their medical device manufacturing footprint in the state is great news for Florida families. After our elimination of the sales tax on manufacturing equipment, job-creating businesses like Covidien are choosing Florida to expand and grow. This announcement is great news and we will continue working hard to provide more jobs and opportunities for Florida families.”
“Covidien’s choice to expand its presence in the state validates Florida’s position as a leader in life sciences and manufacturing,” said Gray Swoope, President and CEO of Enterprise Florida. “The company’s investment and jobs created adds to these extensive sectors. The opportunities created by Covidien will add value to Florida’s workforce and I look forward to seeing their success continue in our state.”
The project was made possible through partnerships between Enterprise Florida, the Tampa Hillsborough Economic Development Corporation, Hillsborough County, Workforce Florida, Inc. and the Florida Department of Economic Opportunity.
“With this announcement, we take another exciting step in the transformative growth of our life sciences industry,” said Hillsborough County Commissioner Ken Hagan. “Covidien now joins an impressive roster of health and medical companies that have recently made the decision to expand in Hillsborough County, including Bristol-Myers Squibb, HealthPlan Services, Synergy Health, Smart Science Labs, LifeLink and Biologics Development Services.”
“By selecting Hillsborough County as the site of its new manufacturing facility, Covidien further validates our efforts to position Tampa Bay as the epicenter of healthcare innovation,” said Allen Brinkman, Chair of the Tampa Hillsborough Economic Development Corporation and Chairman, President and CEO of SunTrust Bank Tampa Bay. “We appreciate their investment in our community, and welcome them to the growing cluster of businesses and research facilities that call the region home.”
“Covidien chose Florida over many other locations because we have established the perfect climate for businesses,” said Jesse Panuccio, Executive Director of the Florida Department of Economic Opportunity. “Our policies support growth across high-impact, high-technology industries – including and especially life sciences. This relocation means 165 families will have new opportunities to share in Florida’s economic turnaround.”